BIO.News Newsletter

As we head into the holiday week, it’s not all bad news: two biotechs leading the charge against sickle cell disease have promising news (including a new therapy for kids) to report. Plus, “clean” is the beauty industry’s favorite buzzword, so we look at what it means and why biotech beauty is making a difference. (790 words, 3 minutes, 57 seconds)

Ending the week with a recap of a banner year for biofuels in the states, plus what policymakers can do to support vaccine manufacturers and global vaccination efforts. (691 words, 3 minutes, 27 seconds)

It’s been a minute since we’ve talked about Build Back Better—here’s the latest on the Senate’s version and the expected timeline. We also look at how gene editing can help solve our massive food waste problem, as well as news alerts from JPM and Georgia Bio. (926 words, 4 minutes, 37 seconds)

Today, we tell you everything you need to know about FDA nominee Dr. Robert Califf’s confirmation hearing yesterday, as well as why a new “little black dress” from Zara is actually green. (754 words, 3 minutes, 46 seconds)

A new study finds the HPV vaccine could eliminate cervical cancer—but we have to tackle vaccine hesitancy. More on that, plus why putting the chicken before the egg could improve the health of both poultry and humans. (838 words, 4 minutes, 11 seconds)

Starting a new week with another important anniversary in the COVID-19 timeline, as well as a deep dive in the plastic problem plaguing our oceans (and how biotech can help solve it). Meanwhile, we’re also keeping an eye on drug price controls in Congress. (767 words, 3 minutes, 50 seconds)

As National Influenza Vaccination Week comes to a close, we look at why everyone needs a flu shot this year—and why policy might harm the next vaccine innovation. Plus, we have news from the Council of State Bioscience Associations (CSBA) and why state policy matters. (751 words, 3 minutes, 45 seconds)

The Energy and Commerce Health Subcommittee held a hearing on U.S. biomedical innovation—here’s what Members and witnesses said about the industry and drug pricing proposals. Meanwhile, we’re still concerned about Mexico’s treatment of biotech—including what it means for animal feed. (817 words, 4 minutes, 5 seconds)

Everyone's talking about COVID-19 antiviral pills developed by Merck/Ridgeback Biotherapeutics and Pfizer. We tell you more about them, plus the latest news on what Maryland's state legislature is doing to support biotech innovation. (607 words, 3 minutes, 2 seconds)

Tomorrow is an important anniversary in the COVID-19 timeline—we look at how far we’ve come and what we need to do to end the pandemic. We also look at the role of leadership in growing the bioeconomy and introduce an innovative CEO and BIO's new climate policy director. (551 words, 2 minutes, 45 seconds)